LINC01634

Across TCGA pan-cancer cohorts, LINC01634 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC01634’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01634 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01634 is over-expressed in tumor, although a few such as COAD and HNSC show the opposite, repressed pattern.

COAD, HNSC, and LUAD are the cancer types where LINC01634 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01634 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.261	<.001	10	view →
HNSC	All	All	−0.426	.001	6	view →
LUAD	All	All	+0.201	<.001	5	view →
READ	All	All	−0.181	<.001	5	view →
UCEC	All	All	−0.079	.005	4	view →
LUSC	All	All	+0.127	.001	3	view →
KIRP	Female	II,III,IV	+0.068	.016	3	view →
LIHC	All	II,III,IV	+0.044	.017	3	view →
PRAD	All	All	−0.177	.003	2	view →
STAD	All	All	−0.144	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC01634–COAD

Open the COAD breakdown →